1. Home
  2. CYTK vs WAY Comparison

CYTK vs WAY Comparison

Compare CYTK & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.41

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Waystar Holding Corp.

WAY

Waystar Holding Corp.

HOLD

Current Price

$34.46

Market Cap

6.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
WAY
Founded
1997
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
6.7B
IPO Year
2004
2024

Fundamental Metrics

Financial Performance
Metric
CYTK
WAY
Price
$62.41
$34.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
15
Target Price
$82.38
$46.53
AVG Volume (30 Days)
2.2M
1.8M
Earning Date
02-26-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.62
Revenue
$87,211,000.00
$1,039,842,000.00
Revenue This Year
$346.43
$16.69
Revenue Next Year
$57.69
$17.44
P/E Ratio
N/A
$55.47
Revenue Growth
2609.26
14.76
52 Week Low
$29.31
$29.40
52 Week High
$70.98
$48.11

Technical Indicators

Market Signals
Indicator
CYTK
WAY
Relative Strength Index (RSI) 49.43 56.02
Support Level $62.05 $31.13
Resistance Level $66.59 $33.72
Average True Range (ATR) 2.97 0.82
MACD 0.09 0.28
Stochastic Oscillator 33.47 98.45

Price Performance

Historical Comparison
CYTK
WAY

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About WAY Waystar Holding Corp.

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

Share on Social Networks: